Detalles de la búsqueda
1.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
N Engl J Med
; 384(14): 1289-1300, 2021 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33616314
2.
Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the "TOWARDS" Score.
Ann Surg Oncol
; 31(5): 3513-3522, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38285306
3.
Higher Donor Age and Severe Microvascular Inflammation Are Risk Factors for Chronic Rejection After Treatment of Active Antibody-Mediated Rejection.
Transpl Int
; 37: 11960, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38371907
4.
Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Jpn J Clin Oncol
; 54(2): 160-166, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37840320
5.
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up.
Jpn J Clin Oncol
; 54(5): 577-583, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38251783
6.
Renal outcome of living kidney donors aged more than 70 years.
Clin Exp Nephrol
; 2024 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38616218
7.
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data.
Int J Clin Oncol
; 29(4): 473-480, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38345708
8.
Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions.
Int J Urol
; 31(1): 73-81, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37798866
9.
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy.
Int J Urol
; 31(4): 355-361, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38146740
10.
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks.
Int J Urol
; 31(4): 422-429, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38193573
11.
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial.
Int J Cancer
; 153(6): 1241-1250, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37294085
12.
Pregnancy Complications and Impact on Kidney Allograft After Kidney Transplantation in IgA Nephropathy.
Transpl Int
; 36: 11220, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37213487
13.
Impact of sex on prognosis in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
Jpn J Clin Oncol
; 53(7): 611-618, 2023 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37002188
14.
Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma.
Jpn J Clin Oncol
; 53(10): 977-983, 2023 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37519060
15.
Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab.
Int J Clin Oncol
; 28(7): 913-921, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37103730
16.
Optimization of first-line systemic therapy in patients with advanced clear cell renal cell carcinoma.
Int J Urol
; 30(9): 705-713, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479730
17.
Long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation: The Japan Academic Consortium of Kidney Transplantation study-II.
Int J Urol
; 30(5): 483-491, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36798048
18.
A single-center retrospective comparative analysis of urinary continence in robotic prostatectomy with a combination of umbilical ligament preservation and Hood technique.
Int J Urol
; 30(10): 889-895, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345368
19.
Comparison of surgical outcomes after robot-assisted laparoscopic partial nephrectomy between patients continuing and discontinuing aspirin therapy: a Japanese single-centre study.
Jpn J Clin Oncol
; 52(5): 499-505, 2022 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35066580
20.
Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up.
Jpn J Clin Oncol
; 52(7): 785-790, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373823